Ofatumumab current price

Ofatumumab is a medicine used to treat adults with relapsing forms of multiple sclerosis (MS) that is given as a subcutaneous injection. Ofatumumab is also available as an injection to treat chronic lymphocytic leukemia (a slowly developing cancer in which too many of a certain type of white blood cell accumulate in the body). OfatumumabThe original drug is already on the market in China and has also been included in medical insurance, with a price of around tens of thousands of yuan. The price of the European version of ofatumumab original drug specifications20mg/0.4mL each sold overseas may be around RMB 16,000 (the price may fluctuate due to the exchange rate). It is expensive and there are currently no generics of ofatumumab for sale.